immunotherapy
209 проекта
H2020Индивидуална стипендия2015–2017Дания
MatrixMacrophages · Matrix degrading macrophages in cancer growth and invasion
H2020Индивидуална стипендия2015–2017Нидерландия
CR-PHAGOCYTOSIS · Complement-mediated phagocytosis in neutrophils
H2020Индивидуална стипендия2015–2017Белгия
ImmunoFarm · IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli.
H2020Индивидуална стипендия2015–2017Нидерландия
CARiPSCTcells · Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application
2 партньори
H2020Индивидуална стипендия2015–2018Обединеното кралство
WORMTUMORS · Worm power: Can helminths modify the development of colorectal cancer?
2 партньори · 2 държави
H2020Индивидуална стипендия2015–2017Обединеното кралство
DC cancer · Development and immunological control of dendritic cell cancer
2 партньори
H2020Индивидуална стипендия2015–2017Обединеното кралство
Tolltum · Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment
H2020Докторантска мрежа2015–2018Испания
IMMUNOSHAPE · Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells
16 партньори · 6 държави
H2020Докторантска мрежа2015–2018Италия
TOLLerant · Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.
10 партньори · 5 държави
FP7Индивидуална стипендия2015–2017Германия
HIV-NOPA · Assessment of functional immune responses of HIV infected individuals without protective HLA-B alleles
FP7Индивидуална стипендия2014–2016Ирландия
RA AND GD T CELLS · The effect of retinoic acid on the fate of γδ T cells
FP7Реинтеграция2013–2017Испания
PRR IN IMMUNOTHERAPY · COMBINATIONAL USE OF INNATE IMMUNE RECEPTORS FOR CANCER IMMUNOTHERAPY
FP7Обмен на изследователи2013–2016Австрия
MODICELL · Targeted Modulation of Immune-System Responses in Cell Therapies
5 партньори · 3 държави
FP7Реинтеграция2012–2016Италия
STEMIMMUNE · Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells
FP7Реинтеграция2012–2016Франция
T9CAN · Transcriptional regulation of IL-9-producing CD4 T cells: use in cancer immunotherapy
FP7Индивидуална стипендия2011–2013Франция
3ITD · Impact of IL-7 and IFNa on nTreg development
FP7Реинтеграция2010–2014Чехия
GCPII_SYSTEM · Design and development of novel reagents, tools, and techniques targeting human glutamate carboxypeptidases II and III
FP7Реинтеграция2010–2012Гърция
NILTHERA · Novel Interleukins for immunotherapy of Asthma
FP7Реинтеграция2009–2013Швеция
CHEMO-IMMUNE THERAPY · A translational approach evaluating novel strategies using chemotherapy to enhance immune-mediated anti-tumor activity
FP7Индивидуална стипендия2008–2011Франция
NK-APC-TREG X-TALK · Cross-talk between NK, APC and regulatory T cells
FP7Индивидуална стипендия2008–2010Швеция
GIFT · Graft engineering to improve allogeneic stem cell transplantation
FP6Индивидуална стипендия2007–2009Гърция
IMMUNOEPIGENETICS · Anti-tumour CD8 immunity influenced by epigenetic alterations
FP6Индивидуална стипендия2006–2008Швейцария
LY49-AUTOIMMUNITY · Regulation of immune responses and autoimmunity by activating and inhibitory NK receptors expressed by T lymphocytes: role of ITAM versus ITIM signal balance
FP6Докторантска мрежа2006–2009Австрия
NK DEFENSE AND THERAPY · Natural killer cell-mediated anti-viral and anti-tumour defence and therapy: Integrated research training in molecular medicine, bioinformatics and issues of patent application and the SME biotech business
12 партньори · 7 държави
